Equities

Poolbeg Pharma PLC

POLB:LSE

Poolbeg Pharma PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)13.00
  • Today's Change-0.05 / -0.38%
  • Shares traded1.08m
  • 1 Year change46.89%
  • Beta--
Data delayed at least 20 minutes, as of Jun 28 2024 15:47 BST.
More ▼

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments121621
Total Receivables, Net0.660.080.06
Total Inventory------
Prepaid expenses0.670.880.45
Other current assets, total------
Total current assets131721
Property, plant & equipment, net------
Goodwill, net------
Intangibles, net1.932.131.56
Long term investments------
Note receivable - long term------
Other long term assets------
Total assets151923
LIABILITIES
Accounts payable0.080.290.08
Accrued expenses0.900.670.36
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total0.010.000.00
Total current liabilities0.990.970.44
Total long term debt000
Total debt000
Deferred income tax------
Minority interest------
Other liabilities, total------
Total liabilities0.990.970.44
SHAREHOLDERS EQUITY
Common stock0.100.100.10
Additional paid-in capital232323
Retained earnings (accumulated deficit)(8.76)(4.88)(0.62)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity141823
Total liabilities & shareholders' equity151923
Total common shares outstanding500500500
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.